31
Participants
Start Date
February 14, 2023
Primary Completion Date
May 26, 2025
Study Completion Date
May 26, 2025
lonigutamab
subcutaneous injection
Placebo
subcutaneous injection
Clinical Research Site, Sydney
Clinical Research Site, East Melbourne
Clinical Research Site, Woolloongabba
Clinical Research Site, Adelaide
Clinical Research Site, Nedlands
Clinical Research Site, New York
Clinical Research Site, East Setauket
Clinical Research Site, Morgantown
Clinical Research Site, Atlanta
Clinical Research Site, Jacksonville
Clinical Research Site, Ann Arbor
ACELYRIN Inc.
INDUSTRY